Kanto Denka Kogyo Co., Ltd. · TSE:4047
Kanto Denka Kogyo — H1 FY2022 Earnings Presentation
31 slides from Kanto Denka Kogyo's earnings presentation, Nov 22, 2022
Slide 1: Financial Results Briefing for the Six Months Ended September 30, 2022
Financial Results Briefing for the Six Months Ended September 30, 2022 Kanto Denka Kogyo Co., Ltd. (Tokyo Stock Exchange Prime Market, Securities Code: 4047) November 22, 2022
Slide 2: Contents
Contents I Overview of Financial Results for the Six Months Ended September 30, 2022 II Business Outlook and Future Trends III Supplementary Materials © Kanto Denka Kogyo Co., Ltd. All rights reserved. 2
Slide 3: I Overview of Financial Results for the Six Months Ended September 30, 2022
I Overview of Financial Results for the Six Months Ended September 30, 2022 © Kanto Denka Kogyo Co., Ltd. All rights reserved. 3
Slide 4: Key Earnings Data
Key Earnings Data Record highs were registered for net sales and each profit indicator for Q2. Sales remained strong. In the Fine Chemicals Division, sales volume was up, with sales increasing significantly as hikes in raw material and fuel prices were passed on to product prices. The Fundamenta
Slide 5: Statement of Income
Statement of Income (Billions of yen) H1 FY2021 H1 FY2022 Difference % change Net sales 28.2 37.3 9.1 32.3 Operating profit 4.4 6.5 2.1 48.9 Ordinary profit 4.3 7.3 2.9 67.6 Profit before income taxes 4.3 7.1 2.8 65.0 Profit attributable to owners of parent 3.0 5.1 2.1 71.2 Basic earnings per share
Slide 6: Balance Sheet
Balance Sheet (Billions of yen) FY2021 H1 FY2022 Difference % change Assets 109.9 114.9 5.0 4.6 Cash and deposits 26.7 18.5 –8.2 –30.7 Trade receivables 18.0 20.2 2.2 12.2 Inventories 13.1 17.7 4.5 34.9 Non-current assets (tangible + intangible) 38.9 44.8 5.8 15.1 Liabilities 49.9 49.3 –0.6 –1.4 Int
Slide 7: Fundamental Chemicals Division
Fundamental Chemicals Division (Billions of yen) H1 FY2021 H1 FY2022 Difference Net sales 3.7 4.1 0.3 Operating profit (loss) (0.08) 0.08 0.16 Net sales ・ Caustic soda: Sales increased due to effects from price revisions, despite lower sales volumes ・ Hydrochloric acid: Sales increased due to effect
Slide 8: Fine Chemicals Division
Fine Chemicals Division (Billions of yen) H1 FY2021 H1 FY2022 Difference Net sales 21.9 30.3 8.3 Operating profit 3.9 6.0 2.0 Net sales ・ Nitrogen trifluoride: Sales increased due to higher sales volumes and effects from price revisions ・ Tungsten hexafluoride: Sales increased due to higher sales vo
Slide 9: Ferrochemicals, Commercial Business, Facilities Divisions
Ferrochemicals, Commercial Business, Facilities Divisions (Including consolidation adjustments) (Billions of yen) H1 FY2021 H1 FY2022 Difference Net sales 2.4 2.8 0.3 Operating profit 0.5 0.4 -0.0 Ferrochemicals Sales and profit were up due to increased sales of carriers Commercial Business Unchange
Slide 10: Consolidated Operating Profit: Difference Analysis
Consolidated Operating Profit: Difference Analysis (H1 FY2021 vs. H1 FY2022) (Billions of yen) 14 12 10 –6.39 +9.17 8 –0.12 –0.49 6 4 7.07 6.54 6.58 2 4.41 4.41 0 (Previous year) Sales/production Raw material and fuel Depreciation Other (Current year) Operating profit prices Operating profit © Kanto
Slide 11: Operating Profit and Operating Profit Margin Over Time (Consolidated)
Operating Profit and Operating Profit Margin Over Time (Consolidated) (Billions of yen) 12 17.9% 20.0% 17.6% 17.6% 17.1% 18.0% 10 14.4% Operating profit 16.0% 0 0 Operating profit margin 14.0% 8 10.9% 12.0% 6 10.0% 11.1 9.4 8.0% 9.0 4 7.7 6.0% 6.5 5.6 4.0% 2 2.0% 0 0.0% FY2017 FY2018 FY2019 FY2020 F
Slide 12: Capital Investment and Depreciation Over Time (Consolidated)
Capital Investment and Depreciation Over Time (Consolidated) (Billions of yen) 20 Capital investment Depreciation 16 12 9.3 H2 target 8 12.2 4.3 10.2 10.1 H2 target 4 8.4 8.0 6.1 5.4 6.7 6.6 4.3 5.0 3.3 0 Investment Depreciation Investment Depreciation Investment Depreciation Investment Depreciation
Slide 13: The Kanto Denka Group (Consolidated Subsidiaries)
The Kanto Denka Group (Consolidated Subsidiaries) (Billions of yen) Share of Net sales: Year-on- Capital Major business lines investment (%) H1 FY2022 year change Sale of chemical products, maintenance Kanden Kosan Co., Ltd. ¥10 mil. 100.0 4.9 1.1 of containers, insurance agency services Manufacture
Slide 14: Business Segments
Business Segments Name Products and services Inorganic products Caustic soda, hydrochloric acid, sodium hypochlorite, aluminum chloride, etc. Fundamental Chemicals Organic products Trichloroethylene, perchloroethylene, vinylidene chloride, cyclohexanol, etc. Sulfur hexafluoride, carbon tetrafluoride
Slide 15: II Business Outlook and Future Trends
II Business Outlook and Future Trends © Kanto Denka Kogyo Co., Ltd. All rights reserved. 15
Slide 16: Performance Forecast By Segment (Consolidated)
Performance Forecast By Segment (Consolidated) (Billions of yen) Net sales Operating profit FY2022 FY2022 FY2022 FY2022 FY2021 FY2021 (results) (initial (revised (results) (initial (revised forecast) forecast) forecast) forecast) Fundamental Chemicals 7.9 8.1 8.9 -0.0 0.1 0.3 Fine Chemicals 49.0 61.
Slide 17: Performance Forecast By Segment: H1 Forecast vs. Results
Performance Forecast By Segment (Consolidated): H1 Forecast vs. Results (Billions of yen) Net sales Operating profit H1 (forecast) H1 (results) Difference H1 (forecast) H1 (results) Difference Fundamental Chemicals 4.1 4.1 0.0 0.0 0.0 0.0 Fine Chemicals 29.0 30.3 1.3 4.6 6.0 1.4 Other* 3.1 2.8 -0.2
Slide 18: Consolidated Operating Profit: Difference Analysis (H1 Initial Forecast vs. Results)
Consolidated Operating Profit: Difference Analysis (H1 Initial Forecast vs. H1 Results) 8.00 (Billions of yen) 7.00 –1.65 +2.36 +0.21 +0.36 6.00 5.00 6.58 4.00 5.30 3.00 2.00 (Forecast) Sales/production Raw material and fuel Depreciation Other (Results) Operating profit prices Operating profit © Kan
Slide 19: Performance Forecast By Segment: H1 vs. H2
Performance Forecast By Segment (Consolidated): H1 vs. H2 (Billions of yen) Net sales Operating profit H1 (results) H2 (forecast) Difference H1 (results) H2 (forecast) Difference Fundamental Chemicals 4.1 4.7 0.6 0.0 0.2 0.1 Fine Chemicals 30.3 37.1 6.8 6.0 4.9 –1.0 Other* 2.8 3.0 0.1 0.4 0.5 0.0 To
Slide 20: Consolidated Operating Profit: Difference Analysis (H1 Result vs. H2 Forecast)
Consolidated Operating Profit: Difference Analysis (H1 Result vs. H2 Forecast) 12.0 Billions of yen 10.0 –4.00 +4.40 8.0 –1.03 6.0 –0.21 4.0 6.58 5.72 2.0 (H1 result) Sales/production Raw material and fuel Depreciation Other (H2 forecast) Operating profit prices Operating profit © Kanto Denka Kogyo
Slide 21: Topics (Status of Major Capital Investments)
Topics (Status of Major Capital Investments) Investment Details Remarks ・Facilities were completed in April 2022 and Hexafluoro-1,3-butadiene shipments are scheduled to begin in H1 of the 260t/yr ⇒ 400t/yr (C4F6) fiscal year ・Additional investment under consideration ・Facilities were completed in Ju
Slide 22: III Supplementary Materials
III Supplementary Materials © Kanto Denka Kogyo Co., Ltd. All rights reserved. 22
Slide 23: Outlook for Major Products: Nitrogen Trifluoride (NF3)
-Outlook for Major Products- Nitrogen Trifluoride (NF3) Chamber cleaning gas for plasma CVD equipment for semiconductor and FPD manufacturing Production capacity: 3,700t/year Demand trends (Kanto Denka forecasts for Forecasted market share tons FY2022 and beyond) ・ Kanto Denka holds over 10% of
Slide 24: Outlook for Major Products: Tungsten Hexafluoride (WF6)
-Outlook for Major Products- Tungsten Hexafluoride (WF6) Wiring material gas for semiconductors Production capacity: 720t/year (Nov. 2016) ➡ 910t/year (Aug. 2018) ➡ 1,400t/year (Oct. 2019) Demand trends (Kanto Denka forecasts for tons FY2022 and beyond) Forecasted market share 10,000 ・ Kanto Den
Slide 25: Outlook for Major Products: Hexafluoro-1,3-butadiene (C4F6)
-Outlook for Major Products- Hexafluoro-1,3-butadiene (C4F6) Etching gas for semiconductors Production capacity: 125t/year ➡ 160t/year (Dec. 2018) ➡ 260t/year (Dec. 2019) ➡ 400t/year (Apr. 2022) Demand trends (Kanto Denka forecasts for tons FY2022 and beyond) Forecasted market share 2,500 ・ Kant
Slide 26: Outlook for Major Products: Carbonyl Sulfide (COS)
-Outlook for Major Products- Carbonyl Sulfide (COS) Etching gas for semiconductors Production capacity: 40t/year ➡ 80t/year (Oct. 2019) ➡ 150t/year (Jun. 2022) Demand trends (Kanto Denka forecasts for tons FY2022 and beyond) Forecasted market share 400 350 ・ Kanto Denka holds 60% or more of mark
Slide 27: Outlook for Major Products: Lithium Hexafluorophosphate (LiPF6)
-Outlook for Major Products- Lithium Hexafluorophosphate (LiPF6) Electrolyte materials for lithium-ion secondary batteries Demand reaches full-scale pace for EVs and other in-vehicle applications Production capacity: 5,400t/year ➡ 10,000t/year (Planned for 2023) Demand trends (Kanto Denka fore
Slide 28: Overseas Production Sites: Kanto Denka Fine Products Korea Co., Ltd.
-Overseas Production Sites- Kanto Denka Fine Products Korea Co., Ltd. Location Cheonan City, South Chungcheong Province, Republic of Korea Business Lines Manufacture and sale of fluorochemicals for semiconductors and FPDs Exterior plant view Production Items ・ Carbonyl sulfide (COS) ・ Carbon t
Slide 29: Overseas Production Sites: Xuancheng KDK Technology Co., Ltd.
-Overseas Production Sites- Xuancheng KDK Technology Co., Ltd. Location Xuancheng City, Anhui Province, People's Republic of China Rendering of completed plant Business Lines Manufacture and sale of fluorochemicals for semiconductors and FPDs Production Items Approx. 250 km Phase I constructio
Slide 30: Kanto Denka's Technology and Business Direction
Kanto Denka's Technology and Business Direction ■ Future SDGs/ESG Significantly strengthen High-sensitivity LIB materials using Polymeriza- analysis recycled Li existing businesses tion Create new business pillars Fine Chemicals Fluorination High purity Fluorochemicals MI* and Battery materials comp
Slide 31: Notes
Notes This document does not constitute disclosure material as defined by the Financial Instruments and Exchange Act and other laws and regulations, and therefore the Company does not guarantee its accuracy or completeness. Performance forecasts in this document were created based on information